TOP 30 Medical laboratory in Danvers, Massachusetts

3 results found

Massachusetts General Hospital Medical Genetics is a premier medical facility dedicated to the evaluation and care of pediatric and adult patients with hereditary, genetic, or metabolic health issues. Located in the Yawkey Center for Outpatient Care, our program is an integral part of Massachusetts General Hospital, a world-renowned academic medical center. Our commitment to fostering a culture of collaboration, pushing the boundaries of medical research, and educating the brightest medical minds ensures that we remain at the forefront of medical innovation. Our Services:

Quest Diagnostics is a leading provider of diagnostic testing, information, and services located at 180 Endicott Street in Danvers, Massachusetts, United States. As a health institution, Quest Diagnostics offers a wide range of laboratory tests and services to help patients and healthcare providers make informed decisions about their health. With a commitment to accuracy, innovation, and quality, Quest Diagnostics is dedicated to improving patient care and outcomes through reliable and timely results.

Dr. David Sweetser is a renowned medical institution located at 102 Endicott Street, Danvers, Massachusetts, United States. Specializing in medical genetics, metabolism, and pediatric hematology/oncology, Dr. Sweetser and his team are dedicated to providing expert care to patients of all ages. With a strong focus on collaboration, medical research, and education, Dr. Sweetser's institution is committed to serving diverse communities and pushing the boundaries of medicine. Dr. Sweetser, a Stanford University graduate, has a wealth of experience in the field of clinical genetics and genomics. His research lab at the Center for Genomic Medicine and MGH Cancer Center is actively engaged in studying genetic disorders such as Pitt Hopkins Syndrome, IQSEC2-related disorder, CACNA1E epileptic encephalopathy, and leukemia. Through patient-derived stem cell models, Dr. Sweetser and his team are developing targeted therapeutics for these conditions.